1
|
Yebes A, Aguilera-Bazán A, Alvarez-Maestro M, Rodriguez-Serrano A, Toribio-Vazquez C, Alonso-Bartolomé M, Ayllón H, Martinez-Perez S, Solano P, Martinez-Piñeiro L. Evolution in the management of high-grade renal trauma over the last two decades: A retrospective review. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00138-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
2
|
Laukhtina E, Moschini M, Krajewski W, Teoh J, Ploussard G, Soria F, Roghmann F, Muenker M, Roumiguie M, Alvarez-Maestro M, Misrai V, Antonelli A, Tafuri A, Simone G, Mastroianni R, Zhao H, Rahota RG, Scuderi S, Petov V, D`andrea D, Mori K, Montorsi F, Enikeev D, Shariat S, Pradere B. Oncological and safety profiles in patients undergoing simultaneous transurethral resection of bladder tumor and prostate: Results from a large multicenter international collaboration. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00331-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
3
|
Afferi L, Lonati C, Montorsi F, Briganti A, Mari A, Schulz G, Black P, Di Trapani E, Karnes R, Mir M, Rink M, Zamboni S, Antonelli A, Tafuri A, Krajewski W, Xylinas E, Soria F, Teoh JC, Mattei A, Albisinni S, Roghmann F, Alvarez-Maestro M, Shariat S, Moschini M. Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)03193-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
4
|
Mattei A, Martini A, Afferi L, Zamboni S, Schultz J, Lonati C, Karnes R, Soligo M, Stabile A, Di Trapani E, De Cobelli O, Simone G, Simeone C, Alvarez-Maestro M, Gandaglia G, Gallina A, Colombo R, Briganti A, Montorsi F, Xylinas E, Shariat S, Moschini M. Oncologic surveillance for variant histology bladder cancer after radical cystectomy. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00983-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
5
|
Afferi L, Lonati C, Montorsi F, Briganti A, Mari A, Schulz G, Black P, Di Trapani E, Karnes R, Mir M, Rink M, Zamboni S, Simeone C, Antonelli A, Tafuri A, Krajewski W, Xylinas E, Soria F, Teoh J, Mattei A, Albisinni S, Roghmann F, Alvarez-Maestro M, Shariat S, Moschini M. Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in pN+ bladder cancer patients. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00860-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
6
|
Marchioni M, Sountoulides P, Furlan M, Mir M, Aretano L, Rubio-Briones J, Alvarez-Maestro M, Bazan A, Antonelli A, Simeone C, Schips L. Management of retroperitoneal recurrence after radical nephrectomy: surgical removal is still the gold standard. results from a multicenter international cohort. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00991-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
7
|
Alvarez-Maestro M, Gomez Rivas J, Moschini M. Surgery for oligometastatic prostate cancer: Where are we going? Actas Urol Esp 2021; 45:479-480. [PMID: 34330693 DOI: 10.1016/j.acuroe.2021.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 02/22/2021] [Indexed: 11/25/2022]
Affiliation(s)
- M Alvarez-Maestro
- Departamento de Urología, Hospital Universitario La Paz, Madrid, Spain.
| | - J Gomez Rivas
- Servicio de Urología, Hospital Clínico de San Carlos, Madrid, Spain
| | - M Moschini
- Departamento de Urología, Luzerner Kantonsspital, Luzern, Switzerland
| |
Collapse
|
8
|
Marchioni M, Sountoulides P, Furlan M, Mir M, Aretano L, Rubio-Briones J, Alvarez-Maestro M, Bazan A, Antonelli A, Simeone C, Schips L. Management of local recurrence after radical nephrectomy: Surgical removal is still the gold standard. Results from a multicenter international cohort. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01028-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
9
|
Afferi L, Lonati C, Montorsi F, Briganti A, Mari A, Krajewski W, Simone G, Schulz G, Black P, Mir M, Roumiguié M, Teoh J, Soria F, Roupret M, Ribal M, Xylinas E, Zamboni S, Antonelli A, Tafuri A, Albisinni S, Mattei A, Alvarez-Maestro M, Shariat S, Moschini M. Ureteral stenting does not increase the risk of metachronous upper tract urothelial carcinoma in patients with bladder cancer presenting with hydronephrosis in comparison with percutaneous nephrostomy: A multicenter analysis. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01206-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Carrión Monsalve D, Gomez Rivas J, Trelles C, Ballesteros Ruiz C, Alvarez-Maestro M, Aguilera Bazan A, Martinez-Piñeiro L. The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01132-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
11
|
Alvarez-Maestro M, Gomez Rivas J, Moschini M. Surgery for oligometastatic prostate cancer: Where are we going? Actas Urol Esp 2021. [PMID: 34023152 DOI: 10.1016/j.acuro.2021.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Couñago F, Alvarez-Maestro M. Are we at the end of adjuvant radiotherapy for prostate cancer? Actas Urol Esp 2021; 45:S0210-4806(21)00085-1. [PMID: 33992447 DOI: 10.1016/j.acuro.2021.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Accepted: 03/19/2021] [Indexed: 10/21/2022]
Affiliation(s)
- F Couñago
- Departamento de Radiología Oncológica, Hospital Universitario Quirón Salud, Madrid, España; Hospital La Luz, Universidad Europea, Madrid, España
| | - M Alvarez-Maestro
- Departamento de Urología. Hospital Universitario La Paz. Madrid. España.
| |
Collapse
|
13
|
Marchioni M, Sountoulides P, Furlan M, Mir C, Aretano L, Rubio-Briones J, Alvarez-Maestro M, Bazán A, Antonelli A, Simeone C, Schips L. Management and survival of patients with retroperitoneal recurrences following radical nephrectomy: Results from a multi-institutional international datasets. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)36164-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
14
|
Afferi L, Moschini M, Mattei A, Mordasini L, Abufaraj M, Soria F, D’Andrea D, Xylinas E, Seisen T, Colin P, Bensalah K, Pradere B, Mari A, Krajewski W, Alvarez-Maestro M, Kikuchi E, Chlosta P, Montorsi F, Briganti A, Simone G, Ornaghi P, Cerruto M, Antonelli A, Matsumoto K, Karakiewicz P, Shariat S. A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35625-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
15
|
Marchioni M, Sountoulides P, Furlan M, Mir C, Aretano L, Rubio-Briones J, Alvarez-Maestro M, Bazan A, Antonelli A, Simeone C, Schips L. Management of retroperitoneal recurrence after radical nephrectomy: Results from a multi-institutional international datasets. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35529-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
16
|
Quesada-Olarte JM, Allaf ME, Alvarez-Maestro M, Martínez-Piñeiro L. Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status. Actas Urol Esp 2020; 44:386-399. [PMID: 32709428 DOI: 10.1016/j.acuro.2019.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Accepted: 12/17/2019] [Indexed: 11/17/2022]
Abstract
INTRODUCTION The clinical course of Prostate cancer (PCa) are markedly diverse, ranging from indolent to highly aggressive disseminated disease. Molecular imaging techniques are playing an increasing role in early PCa detection, staging and disease recurrence. There are some molecular imaging modalities, radiotracers agents and its performance are important in current clinical practice PCa. OBJECTIVE This review summarizes the latest information regarding molecular imaging of PCa and is designed to assist urologists with ordering and interpreting these modalities and different radiotracers for different patients. EVIDENCE ACQUISITION A PubMed-based literature search was conducted up to September 2019. We selected the most recent and relevant original articles, metanalysis and reviews that have provided relevant information to guide molecular imaging modalities and radiotracers use. EVIDENCE SYNTHESIS In this review, we discuss 3 main molecular imaging modalities and 7 radiotracer technologies available. CONCLUSIONS The use molecular imaging modalities and radiotracers has a unique role in biochemical recurrence and diagnosis of ganglionar and bone progression of PCa. In the present time, no one of these molecular imaging modalities can be recommended over the classical work-up of abdominopelvic CT scan and bone scan, and large-scale and multi-institutional studies are required to validate the efficacy and cost utility of these new technologies.
Collapse
Affiliation(s)
| | - M E Allaf
- Departamento de Urología, Johns Hopkins University Hospital, Baltimore, Estados Unidos
| | | | | |
Collapse
|
17
|
Carando R, Pradere B, Afferi L, Marra G, Aziz A, Roghmann F, Krajewski W, Di Bona C, Alvarez-Maestro M, Pagliarulo V, Xylinas E, Moschini M. The role of device-assisted therapies in the management of non-muscle invasive bladder cancer: A systematic review. Prog Urol 2020; 30:322-331. [PMID: 32279953 DOI: 10.1016/j.purol.2020.03.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2020] [Revised: 02/15/2020] [Accepted: 03/12/2020] [Indexed: 12/12/2022]
Abstract
OBJECTIVE Despite optimal treatment, patients affected by non-muscle invasive bladder cancer (NMIBC) suffer from high risk of recurrence and progression. Intravescical device assisted therapies such as radiofrequency induced thermochemotherapeutic effect (RITE) and electromotive drug administration (EMDA) have shown promising effect in enhancing the effect of intravescical chemotherapies. The aim of the study was to assess clinical outcomes of these two devices in non-muscle invasive bladder cancer. METHODS A systematic literature review was performed in December 2019 using the Medline, Embase, and Web of Science databases. Only articles published in the last 10 years were considered (2009-2019). The articles were selected using the following keywords association: "bladder cancer" AND "EMDA' AND "synergo" AND "hyperchemotherapy" AND "electromotive drug administration", AND "radiofrequency induced thermochemotherapeutic" AND "RITE". RESULTS We found 16 studies published in the last ten years regarding the efficacy of RITE (12 studies) and EMDA (4 studies) in the treatment of NMIBC. Both RITE and EMDA showed promising results in the treatment of intermediate and high risk NMIBC as well as in patients affected by recurrent BCa after BCG failure. In high-risk BCG naïve NMIBC patients treated with EMDA recurrence and progression rates were 68% and 95%, respectively. Considering RITE, recurrence and progression range rates were 43%-88% and 62%-97%, respectively. Discordance results were reported regarding its effect on patients with carcinoma in situ. However, only few studies could be compared since differences exist regarding inclusion criteria with high patients' heterogeneity. Considering recurrence after BCG, recurrence and progression range rates were 29%-29.2% and 62%-83% for RITE and 25% and 75% for EMDA, respectively. CONCLUSION Delivery of intravescical hyperthermia seems to enhance the normal effect of intravescical chemotherapy instillation. Although prospective trials supported its effect on both BCG naïve and BCG failure patients, data are urgently required to validate these findings and to understand its effect on patients with carcinoma in situ. LEVEL OF PROOF 3.
Collapse
Affiliation(s)
- R Carando
- Clinica Luganese Moncucco, Lugano, Switzerland; Clinica S. Anna, Swiss Medical Group, Sorengo, Switzerland; Clinica Santa Chiara, Locarno, Switzerland; Department of Urology, Luzerner Kantonsspital, Spitalstrasse, 6000 Luzern, Switzerland.
| | - B Pradere
- Department of Urology, Centre Hospitalier Universitaire Tours, Tours, France; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
| | - L Afferi
- Department of Urology, Luzerner Kantonsspital, Spitalstrasse, 6000 Luzern, Switzerland
| | - G Marra
- Division of Urology, Department of Surgical Sciences, University of Studies of Torino, Turin, Italy
| | - A Aziz
- Department of Urology, University Medical Center Rostock, Rostock, Germany
| | - F Roghmann
- Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany
| | - W Krajewski
- Department of Urology and Oncologic Urology, Wrocław Medical University, Wroclaw, Poland
| | - C Di Bona
- Department of Urology, Luzerner Kantonsspital, Spitalstrasse, 6000 Luzern, Switzerland
| | - M Alvarez-Maestro
- Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain
| | - V Pagliarulo
- Department of Urology, University "Aldo Moro", Bari, Italy
| | - E Xylinas
- Department of Urology Bichat Hospital, Paris Descartes University, Paris, France
| | - M Moschini
- Department of Urology, Luzerner Kantonsspital, Spitalstrasse, 6000 Luzern, Switzerland
| |
Collapse
|
18
|
Gómez-Rivas J, Rodríguez-Socarrás M, Tortolero-Blanco L, Garcia-Sanz M, Alvarez-Maestro M, Ribal M, Cózar-Olmo M. Influence of social networks on congresses of urological societies and associations: Results of the 81th National Congress of the Spanish Urological Association. Actas Urol Esp 2017; 41:181-187. [PMID: 27894612 DOI: 10.1016/j.acuro.2016.09.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2016] [Accepted: 09/03/2016] [Indexed: 10/20/2022]
Abstract
OBJECTIVE To measure social network activity during the 81th National Congress of the Spanish Urological Association (AEU) and to compare it with the activity during other congresses of national and international urological associations. MATERIAL AND METHODS We designed and registered the official hashtag #AEU16 for the 81th National Congress of the AEU on the Symplur website. The following measurements were recorded: number of participants, number of tweets, tweets by participant, tweets per hour and views. RESULTS The number of participants in the social network activity during the congress was 207. The measurements of activity in Twitter consisted of a total of 1866 tweets, a mean rate of 16 tweets/h, 9 tweets per participant and 1,511,142 views. The activity during the international congresses is as follows: 2016 American Urological Association annual congress (views: 28,052,558), 2016 European Association of Urology annual congress (views: 13,915,994), 2016 Urological Society of Australia and New Zealand (views: 4,757,453), 2015 Société Internationale d'Urologie annual congress (views: 1,023,038). The activity during the national congresses was recorded as follows: 2016 Annual Conference of The British Association of Urological Surgeons (views: 2,518,880), 81th National Congress of the AEU (views: 1,511,142), 109th Congress of l'Association Française d'Urologie (views: 662,828), 67th German Congress of Urology (views: 167,347). We found 10 posts in Facebook and 2 communications via Periscope TV related to #AEU16. CONCLUSIONS The social network activity during the 81th National Congress of the AEU was notable given the results of this study. The use of social networks has expanded among urological associations, congresses and meetings, giving them a global character.
Collapse
|
19
|
Alvarez-Maestro M, Rios Gonzalez E, Martinez-Piñeiro L, Sanchez Gomez FJ. Modified endoscopic left inguinal lymphadenectomy. Actas Urol Esp 2013; 37:663-6. [PMID: 23768501 DOI: 10.1016/j.acuro.2013.02.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2012] [Revised: 01/12/2013] [Accepted: 02/09/2013] [Indexed: 11/17/2022]
Abstract
INTRODUCTION Endoscopic Inguinal Lymphadenectomy is an evolution of laparoscopic surgery thanks to background in these techniques. This is a new technique and the indications in the field of penile tumors today are expanding. The technique aims at reducing the morbidity of the procedure without compromising the cancer control or reducing the template of the dissection. MATERIAL AND METHODS We present the modified endoscopic inguinal lymphadenectomy in a 70 years-old male patient with penile melanoma and positive sentinel lymph node in left inguinal limb. Intraoperative data, pathology, post operatory evolution and oncological follow-up is described RESULTS Operative time was 120 min. Nine lymph nodes were retrieved and none of then showed positivity at pathology. There were no complications. The drain was kept for five days. After 12 months of follow up, no signs of disease progression were noted. CONCLUSION The endoscopic inguinal lymphadenectomy is feasible in clinical practice. New studies with a greater number of patients and long-term follow-up may confirm the oncological efficacy and possible lower morbidity of these new approach.
Collapse
Affiliation(s)
- M Alvarez-Maestro
- Departamento de Urología, Hospital Universitario Infanta Sofía, Madrid, España.
| | | | | | | |
Collapse
|